Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about GSK
Recent news which mentions GSK
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
UK Chooses Pfizer Over GSK for Multi-Million Dose RSV Vaccine Contract
June 24, 2024
Tickers
GSK
NEWS
PFE
Tags
News
Top Stories
General
From
Benzinga
Industry Groups Back GSK's Effort To Halt 70,000 Lawsuits Associated With Heartburn Drug Zantac Caused Cancer
June 20, 2024
Tickers
GSK
NEWS
PFE
SNY
Tags
SNY
Market News
Equities
From
Benzinga
Analyst Projects Strong Growth for GSK-Innoviva Partnered Respiratory Drugs
June 18, 2024
Tickers
GSK
INVA
NEWS
Tags
Trading Ideas
Briefs
Initiation
From
Benzinga
7 A-Rated Biotech Stocks Worth Betting on in June
June 14, 2024
Tickers
ABBV
CADL
GSK
LEXX
Tags
OCGN
LLY
LEXX
From
InvestorPlace
3 Penny Stocks That Can Deliver Over 5,000% Upside by 2025: June Edition
June 11, 2024
Tickers
GSK
ME
SVRA
VIGL
Tags
GSK
VIGL
Stocks to Buy
From
InvestorPlace
The 3 Most Undervalued Pharma Stocks to Buy in June 2024
June 06, 2024
Tickers
BIIB
ESAIY
GSK
LLY
Tags
VKTX
NYSE:NVO,NYSE:GSK,OTCMKTS:ESAIY,NYSE:LLY,NASDAQ:BIIB,NASDAQ:VKTX
GSK
From
InvestorPlace
GSK Stock Falls as 70,000 Zantac Lawsuits Move Forward. What to Know.
June 03, 2024
Tickers
GSK
Tags
NYSE:GSK
GSK
Today's Market
From
InvestorPlace
GSK's Blenrep Combo Therapy Cuts Risk Of Disease Progression Or Death By Around 50% In Pretreated Multiple Myeloma
June 03, 2024
Tickers
GSK
NEWS
Tags
Briefs
General
Top Stories
From
Benzinga
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 03, 2024
Tickers
ADRT
ADSK
AFMD
AMC
Tags
LPA
LSCC
ZIM
From
Benzinga
Zantac Heart Burn Continues For GSK As US Court Ruling Allows Thousands Of Zantac Lawsuits To Move Forward
June 03, 2024
Tickers
GSK
NEWS
SNY
Tags
SNY
Market News
Health Care
From
Benzinga
GSK, Boston Beer And Other Big Stocks Moving Lower In Monday's Pre-Market Session
June 03, 2024
Tickers
AVXL
BWLP
CMPS
GSK
Tags
CMPS
News
AVXL
From
Benzinga
Is Moderna Stock a Buy Now That It's a 2-Product Company?
June 03, 2024
Tickers
GSK
MRNA
PFE
Tags
PFE
Market News
Recent Press Releases
From
Motley Fool
Why GameStop Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
June 03, 2024
Tickers
ABTS
AMC
BNAI
CRKN
Tags
EEIQ
HGAS
Premarket Movers
From
Benzinga
Moderna Investors Just Got Some Bullish News
June 03, 2024
Tickers
GSK
MRNA
PFE
Tags
Recent Press Releases
Market News
GSK
From
Motley Fool
AstraZeneca, Merck, GSK Struck Record $44.1B Licensing Deals With Chinese Drugmakers In 2023: Report
May 27, 2024
Tickers
ASIA
AZN
GSK
MRK
Tags
pharmaceutical companies
General
News
From
Benzinga
Zantac Verdict: Jury Finds No Link To Colon Cancer In Initial Trial, GSK And Boehringer Prevail In First Zantac Cancer Lawsuit
May 24, 2024
Tickers
GSK
NEWS
PFE
SNY
Tags
Large Cap
Stories That Matter
Benzinga
From
Benzinga
First Advanced Oral Treatment For Asthma - Sanofi's Investigational Drug Shows Potential
May 22, 2024
Tickers
GSK
NEWS
SNY
Tags
Top Stories
News
SNY
From
Benzinga
GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims
May 21, 2024
Tickers
GSK
NEWS
PFE
Tags
PFE
General
Top Stories
From
Benzinga
GSK's Experimental Asthma Drug Reduces Severe Attacks, Phase 3 Trial Data Shows
May 21, 2024
Tickers
GSK
NEWS
Tags
General
News
Top Stories
From
Benzinga
GSK Completely Exits Sensodyne Toothpaste Maker Haleon In $1.6B Sale
May 17, 2024
Tickers
GSK
HLN
NEWS
PFE
Tags
PFE
General
Top Stories
From
Benzinga
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
May 16, 2024
Tickers
ABB
AZN
BAYRY
GSK
Tags
MYNZ
Biotech
GSK
From
Benzinga
Patent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade
May 16, 2024
Tickers
AMPH
AMRX
GSK
LLY
Tags
PFE
Stocks to Sell
TEVA
From
InvestorPlace
Double-Up Delights: 7 Stocks Poised to Soar 100% by 2025
May 14, 2024
Tickers
ARWR
GSK
JOBY
MATW
Tags
NVTS
NVCR
GSK
From
InvestorPlace
Is This a Setback for Moderna?
May 14, 2024
Tickers
GSK
MRNA
PFE
Tags
PFE
MRNA
GSK
From
Motley Fool
Amazon Pours ~$1.3B Investment Into French Operations: Report
May 13, 2024
Tickers
ACN
AMZN
GOOGL
GSK
Tags
Media
Market News
Equities
From
Benzinga
FDA Delays 'Important' Moderna Vaccine Review: William Blair Says 2025 Growth, '2026 Breakeven Story' Depends On It
May 10, 2024
Tickers
GSK
MRNA
NEWS
PFE
Tags
Earnings
Large Cap
Stories That Matter
From
Benzinga
Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2
May 09, 2024
Tickers
AZN
EWTX
GSK
NEWS
Tags
health care stocks
Market News
Expert Ideas
From
Benzinga
Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks Associated With Discontinued Heartburn Drug Zantac
May 08, 2024
Tickers
GSK
NEWS
PFE
SNY
Tags
Briefs
Zantac
Legal
From
Benzinga
7 Sleeper Stocks to Buy Before Wall Street Wakes Up: April 2024
May 01, 2024
Tickers
AFRM
D
GSK
IIPR
Tags
SUN
IIPR
AFRM
From
InvestorPlace
GSK Stock Earnings: GSK Beats EPS, Beats Revenue for Q1 2024
May 01, 2024
Tickers
GSK
Tags
GSK
Earnings Reports
Market News
From
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.